Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: A cross-sectional study

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Maripuu, Martin ^a   Wikgren, Mikael ^a   Karling, Pontus ^a   Adolfsson, Rolf ^a   Norrback, Karl Fredrik ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; DEXAMETHASONE;

ADRENAL CORTEX INSUFFICIENCY; ADULT; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEGATIVE FEEDBACK; PHYSICAL CAPACITY; QUALITY OF LIFE; RELIGION; SEX RATIO; SOCIAL INTERACTION; BIPOLAR DISORDER; DEPRESSION; HYPOPHYSIS ADRENAL SYSTEM; METABOLISM; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSION; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE;

EID: 84903300885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098682     Document Type: Article

References (72)

1. Belmaker RH (2004) Bipolar disorder. N Engl J Med 351: 476-486.
2. Judd LL, Akiskal HS (2003) Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder. Curr Psychiatry Rep 5: 417-418. (Pubitemid 38899236)
3. Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, et al. (2003) A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60: 261-269. (Pubitemid 36307437)
4. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Leon AC, et al. (2005) Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry 62: 1322-1330. (Pubitemid 41746610)
5. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, et al. (2002) The longterm natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59: 530-537. (Pubitemid 34602935)
6. Hirschfeld RM (2004) Bipolar depression: the real challenge. Eur Neuropsychopharmacol 14 Suppl 2: S83-88.
7. Kupfer DJ, Frank E, Grochocinski VJ, Cluss PA, Houck PR, et al. (2002) Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry 63: 120-125. (Pubitemid 34173848)
8. Michalak EE, Murray G, Young AH, Lam RW (2008) Burden of bipolar depression: impact of disorder and medications on quality of life. CNS Drugs 22: 389-406. (Pubitemid 351508123)
9. Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5: 374-381.
10. Carroll BJ (1982) The dexamethasone suppression test for melancholia. Br J Psychiatry 140: 292-304.
11. Daban C, Vieta E, Mackin P, Young AH (2005) Hypothalamic-pituitary- adrenal axis and bipolar disorder. Psychiatr Clin North Am 28: 469-480.
12. Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker CR, Jr., et al. (1996) The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 57: 470-484. (Pubitemid 26362312)
13. Rybakowski JK, Twardowska K (1999) The dexamethasone/ corticotropinreleasing hormone test in depression in bipolar and unipolar affective illness. J Psychiatr Res 33: 363-370. (Pubitemid 29392684)
14. Schmider J, Lammers CH, Gotthardt U, Dettling M, Holsboer F, et al. (1995) Combined dexamethasone/corticotropin-releasing hormone test in acute and remitted manic patients, in acute depression, and in normal controls: I. Biol Psychiatry 38: 797-802. (Pubitemid 3020006)
15. Stetler C, Miller GE (2011) Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med 73: 114-126.
16. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH (2004) Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 184: 496-502. (Pubitemid 38725709)
17. Kaushik ML, Sharma RC (2003) Addison's disease presenting as depression. Indian J Med Sci 57: 249-251. (Pubitemid 39663745)
18. Sonino N, Fallo F, Fava GA (2010) Psychosomatic aspects of Cushing's syndrome. Rev Endocr Metab Disord 11: 95-104.
19. Sonino N, Fava GA (1998) Psychosomatic aspects of Cushing's disease. Psychother Psychosom 67: 140-146. (Pubitemid 28291336)
20. Sonino N, Fava GA (2001) Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 15: 361-373. (Pubitemid 32487993)
21. Miller GE, Chen E, Zhou ES (2007) If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull 133: 25-45.
22. Fries E, Hesse J, Hellhammer J, Hellhammer DH (2005) A new view on hypocortisolism. Psychoneuroendocrinology 30: 1010-1016. (Pubitemid 40982486)
23. Heim C, Ehlert U, Hellhammer DH (2000) The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 25: 1-35. (Pubitemid 29490865)
24. Bremmer MA, Deeg DJ, Beekman AT, Penninx BW, Lips P, et al. (2007) Major depression in late life is associated with both hypo- and hypercortisolemia. Biol Psychiatry 62: 479-486. (Pubitemid 47284034)
25. Morrison MF, Redei E, TenHave T, Parmelee P, Boyce AA, et al. (2000) Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population. Biol Psychiatry 47: 144-150. (Pubitemid 30069738)
26. Oldehinkel AJ, van den Berg MD, Flentge F, Bouhuys AL, ter Horst GJ, et al. (2001) Urinary free cortisol excretion in elderly persons with minor and major depression. Psychiatry Res 104: 39-47. (Pubitemid 32964783)
27. Penninx BW, Beekman AT, Bandinelli S, Corsi AM, Bremmer M, et al. (2007) Late-life depressive symptoms are associated with both hyperactivity and hypoactivity of the hypothalamo-pituitary-adrenal axis. Am J Geriatr Psychiatry 15: 522-529.
28. Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1: 336-342.
29. Wikgren M, Maripuu M, Karlsson T, Nordfjall K, Bergdahl J, et al. (2012) Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry 71: 294-300.
30. Yehuda R (2009) Status of glucocorticoid alterations in post-traumatic stress disorder. Ann N Y Acad Sci 1179: 56-69.
31. Spijker AT, van Rossum EF (2012) Glucocorticoid sensitivity in mood disorders. Neuroendocrinology 95: 179-186.
32. da Rocha NS, Power MJ, Bushnell DM, Fleck MP (2009) Is there a measurement overlap between depressive symptoms and quality of life? Compr Psychiatry 50: 549-555.
33. Rapaport MH, Clary C, Fayyad R, Endicott J (2005) Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry 162: 1171-1178. (Pubitemid 40770701)
34. IsHak WW, Brown K, Aye SS, Kahloon M, Mobaraki S, et al. (2012) Healthrelated quality of life in bipolar disorder. Bipolar Disord 14: 6-18.
35. IsHak WW, Greenberg JM, Balayan K, Kapitanski N, Jeffrey J, et al. (2011) Quality of life: the ultimate outcome measure of interventions in major depressive disorder. Harv Rev Psychiatry 19: 229-239.
36. Brenner K, St-Hilaire A, Liu A, Laplante DP, King S (2011) Cortisol response and coping style predict quality of life in schizophrenia. Schizophr Res 128: 23-29.
37. Gustafsson PE, Janlert U, Virtanen P, Hammarstrom A (2012) The association between long-term accumulation of temporary employment, the cortisol awakening response and circadian cortisol levels. Psychoneuroendocrinology 37: 789-800.
38. van Aken MO, Pereira AM, Biermasz NR, van Thiel SW, Hoftijzer HC, et al. (2005) Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 90: 3279-3286. (Pubitemid 41014287)
39. Fountoulakis KN, Gonda X, Rihmer Z, Fokas C, Iacovides A (2008) Revisiting the Dexamethasone Suppression Test in unipolar major depression: an exploratory study. Ann Gen Psychiatry 7: 22.
40. Association AP (1994) Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Publishing.
41. Nilsson L-G, Bäckman L, Erngrund K, Nyberg L, Adolfsson R, et al. (1997) The Betula prospective cohort study: Memory, health, and aging. Aging Neuropsychol Cogn 4: 1-32. (Pubitemid 27245220)
42. Nilsson L-G, Adolfsson R, Bäckman L, de Frias CM, Molander B, et al. (2004) Betula: A Prospective Cohort Study on Memory, Health and Aging. Aging Neuropsychol Cogn 11: 134-148. (Pubitemid 39387199)
43. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
44. Svanborg P, Asberg M (1994) A new self-rating scale for depression and anxiety states based on the Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 89: 21-28. (Pubitemid 24028261)
45. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389. (Pubitemid 9136500)
46. Beck AT, Epstein N, Brown G, Steer RA (1988) An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 56: 893-897. (Pubitemid 19008360)
47. Tyrer P, Owen RT, Cicchetti DV (1984) The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. J Neurol Neurosurg Psychiatry 47: 970-975.
48. Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G (1978) A comprehensive psychopathological rating scale. Acta Psychiatr Scand Suppl: 5-27. (Pubitemid 8341005)
49. Bodlund O, Kullgren G, Ekselius L, Lindstrom E, von Knorring L (1994) Axis V-Global Assessment of Functioning Scale. Evaluation of a self-report version. Acta Psychiatr Scand 90: 342-347. (Pubitemid 24331606)
50. Group TW (1998) The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties. Social Science & Medicine 46: 1569-1585.
51. Karling P, Norrback KF, Adolfsson R, Danielsson A (2007) Gastrointestinal symptoms are associated with hypothalamic-pituitary-adrenal axis suppression in healthy individuals. Scand J Gastroenterol 42: 1294-1301. (Pubitemid 47537074)
52. Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, et al. (2001) Tissuespecific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86: 1418-1421. (Pubitemid 32323037)
53. Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, et al. (2002) Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 87: 3330-3336. (Pubitemid 34816385)
54. Michalak EE, Yatham LN, Lam RW (2005) Quality of life in bipolar disorder: a review of the literature. Health Qual Life Outcomes 3: 72.
55. Brown ES (2009) Effects of glucocorticoids on mood, memory, and the hippocampus. Treatment and preventive therapy. Ann N Y Acad Sci 1179: 41-55.
56. Kenna HA, Poon AW, de los Angeles CP, Koran LM (2011) Psychiatric complications of treatment with corticosteroids: review with case report. Psychiatry Clin Neurosci 65: 549-560.
57. Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22: 111-122. (Pubitemid 30072057)
58. Plihal W, Krug R, Pietrowsky R, Fehm HL, Born J (1996) Corticosteroid receptor mediated effects on mood in humans. Psychoneuroendocrinology 21: 515-523. (Pubitemid 27061941)
59. Schmidt LA, Fox NA, Goldberg MC, Smith CC, Schulkin J (1999) Effects of acute prednisone administration on memory, attention and emotion in healthy human adults. Psychoneuroendocrinology 24: 461-483. (Pubitemid 29204806)
60. Angst J, Sellaro R (2000) Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 48: 445-457.
61. Wittchen HU, Mhlig S, Pezawas L (2003) Natural course and burden of bipolar disorders. Int J Neuropsychopharmacol 6: 145-154.
62. Pfennig A, Kunzel HE, Kern N, Ising M, Majer M, et al. (2005) Hypothalamus-pituitary- adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 57: 336-342. (Pubitemid 40215762)
63. Bschor T, Baethge C, Adli M, Eichmann U, Ising M, et al. (2003) Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder. J Psychiatr Res 37: 135-143. (Pubitemid 36808476)
64. Bschor T, Ritter D, Winkelmann P, Erbe S, Uhr M, et al. (2011) Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients. PLoS One 6: e27613.
65. Bouwer C, Claassen J, Dinan TG, Nemeroff CB (2000) Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series. Depress Anxiety 12: 44-50.
66. DeBattista C, Posener JA, Kalehzan BM, Schatzberg AF (2000) Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study. Am J Psychiatry 157: 1334-1337. (Pubitemid 30659822)
67. Arana GW, Santos AB, Laraia MT, McLeod-Bryant S, Beale MD, et al. (1995) Dexamethasone for the treatment of depression: a randomized, placebocontrolled, double-blind trial. Am J Psychiatry 152: 265-267.
68. Beale MD, Arana GW (1995) Dexamethasone for treatment of major depression in patients with bipolar disorder. Am J Psychiatry 152: 959-960.
69. Quiroz JA, Singh J, Gould TD, Denicoff KD, Zarate CA, et al. (2004) Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology. Mol Psychiatry 9: 756-776. (Pubitemid 39107965)
70. Ambrogio AG, Pecori Giraldi F, Cavagnini F (2008) Drugs and HPA axis. Pituitary 11: 219-229.
71. Dantzer R (2012) Depression and inflammation: an intricate relationship. Biol Psychiatry 71: 4-5.
72. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, et al. (2010) A metaanalysis of cytokines in major depression. Biol Psychiatry 67: 446-457.